{"title":"Influence of therapy continuous positive airway pressure on arterial stiffness in patients with arterial hypertension and obstructive sleep apnea","authors":"O. Rekovets, Y. Sirenko, N. Krushynska, O. Torbas","doi":"10.31928/2664-4479-2022.5-6.1729","DOIUrl":null,"url":null,"abstract":"The aim – to assess the arterial stiffness changes in patients with arterial hypertension (AH) and obstructive sleep apnea (OSA) and possibilities of its correction by continuous positive airway pressure (CPAP)-therapy.Materials and methods. 185 patients with mild and moderate AH (49.8±0.8 years old) were enrolled in the study and divided into groups: 1st group – patients who had OSA (n=148), 2nd group – patients without OSA (control group, n=37). They underwent clinical and special examination: unattended somnography by dual-channel portable monitor device, estimation of daily sleepiness by Epworth Sleepiness Scale, office and ambulatory blood pressure monitoring, echocardiography and applanation tonometry. In 10 months follow-up study were included 105 patients, who were divided into 4 subgroups: A – patients with moderate to severe OSA on CPAP (n=23); B – patients with moderate to severe OSA without CPAP (n=29); C – patients with mild OSA (n=29); D – patients without OSA (controls, n=24). All patients received similar antihypertensive therapy according to 2013 ESH/ESC Guidelines.Results and discussion. Patients with AH and OSA (mean apnea-hypopnea index (AHI) 38.10±2.51 event/h) in comparison with patients without OSA (mean AHI 3.02±0.25 event/h) had significantly higher body mass index (35.20±0.57 vs 30.60±0.79 kg/m, p<0.001), blood glucose level (107.2±2.2 vs 98.0±2.5 mg/dl, p=0.045), uric acid level (6.17±0.10 vs 5.5±0.3 mg/dl, p=0.048) and left ventricular mass index (LVMI) (115.80±2.39 vs 104.60±4.56 g/m, p=0.035). Also the patients with AH and OSA in comparison with patients without OSA had higher carotid-femoral pulse wave velocity (PWVcf) (11.19±0.20 vs 10.10 m/s, p=0.014) and central systolic blood pressure (CSBP) (133.43±1.67 vs 125.22±3.41 mm Hg, p=0.027). During 10 month follow-up in patients with AH and OSA on CPAP-therapy there were significantly decrease of PWVcf (from 12.20±0.63 to 10.05±0.43 m/s, p=0.009) with achievement of normal level (<10 m/s) in 60.9 % patients, office systolic blood pressure (from 143.8±132.7 to 132.70±2.33 mm Hg, p=0.021) and diastolic blood pressure (from 93.80±3.31 to 86.00±3.19 mm Hg, p=0.012) with achievement of target levels. In patients central systolic BP decreased (from 130.30±3.97 to 119.70±2.97 mm Hg, p=0.012) and diastolic BP decreased (from 94.70±3.31 to 87.10±2.36 mm Hg, p=0.013).Conclusions. Combination of continuous positive airway pressure (CPAP)-therapy and antihypertensive treatment had decrease of arterial stiffness and helps to achieve target blood pressure in patients with AH and moderate to severe OSA.","PeriodicalId":23419,"journal":{"name":"Ukrainian Journal of Cardiology","volume":"43 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukrainian Journal of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31928/2664-4479-2022.5-6.1729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The aim – to assess the arterial stiffness changes in patients with arterial hypertension (AH) and obstructive sleep apnea (OSA) and possibilities of its correction by continuous positive airway pressure (CPAP)-therapy.Materials and methods. 185 patients with mild and moderate AH (49.8±0.8 years old) were enrolled in the study and divided into groups: 1st group – patients who had OSA (n=148), 2nd group – patients without OSA (control group, n=37). They underwent clinical and special examination: unattended somnography by dual-channel portable monitor device, estimation of daily sleepiness by Epworth Sleepiness Scale, office and ambulatory blood pressure monitoring, echocardiography and applanation tonometry. In 10 months follow-up study were included 105 patients, who were divided into 4 subgroups: A – patients with moderate to severe OSA on CPAP (n=23); B – patients with moderate to severe OSA without CPAP (n=29); C – patients with mild OSA (n=29); D – patients without OSA (controls, n=24). All patients received similar antihypertensive therapy according to 2013 ESH/ESC Guidelines.Results and discussion. Patients with AH and OSA (mean apnea-hypopnea index (AHI) 38.10±2.51 event/h) in comparison with patients without OSA (mean AHI 3.02±0.25 event/h) had significantly higher body mass index (35.20±0.57 vs 30.60±0.79 kg/m, p<0.001), blood glucose level (107.2±2.2 vs 98.0±2.5 mg/dl, p=0.045), uric acid level (6.17±0.10 vs 5.5±0.3 mg/dl, p=0.048) and left ventricular mass index (LVMI) (115.80±2.39 vs 104.60±4.56 g/m, p=0.035). Also the patients with AH and OSA in comparison with patients without OSA had higher carotid-femoral pulse wave velocity (PWVcf) (11.19±0.20 vs 10.10 m/s, p=0.014) and central systolic blood pressure (CSBP) (133.43±1.67 vs 125.22±3.41 mm Hg, p=0.027). During 10 month follow-up in patients with AH and OSA on CPAP-therapy there were significantly decrease of PWVcf (from 12.20±0.63 to 10.05±0.43 m/s, p=0.009) with achievement of normal level (<10 m/s) in 60.9 % patients, office systolic blood pressure (from 143.8±132.7 to 132.70±2.33 mm Hg, p=0.021) and diastolic blood pressure (from 93.80±3.31 to 86.00±3.19 mm Hg, p=0.012) with achievement of target levels. In patients central systolic BP decreased (from 130.30±3.97 to 119.70±2.97 mm Hg, p=0.012) and diastolic BP decreased (from 94.70±3.31 to 87.10±2.36 mm Hg, p=0.013).Conclusions. Combination of continuous positive airway pressure (CPAP)-therapy and antihypertensive treatment had decrease of arterial stiffness and helps to achieve target blood pressure in patients with AH and moderate to severe OSA.
目的是评估动脉高血压(AH)和阻塞性睡眠呼吸暂停(OSA)患者的动脉硬度变化以及持续气道正压通气(CPAP)治疗对其纠正的可能性。材料和方法。185例轻中度AH患者(49.8±0.8岁)被纳入研究,分为两组:第一组有OSA患者(n=148),第二组无OSA患者(对照组,n=37)。他们接受了临床和特殊检查:使用双通道便携式监护仪进行无人监护的睡眠描记,使用Epworth嗜睡量表评估每日嗜睡程度,办公室和动态血压监测,超声心动图和压胸测压。在10个月的随访研究中纳入105例患者,将其分为4个亚组:A - CPAP治疗中重度OSA患者(n=23);B -无CPAP的中重度OSA患者(n=29);C -轻度OSA患者(n=29);D -无OSA患者(对照组,n=24)。所有患者均按照2013年ESH/ESC指南接受类似的降压治疗。结果和讨论。AH合并OSA患者(平均呼吸暂停-低通气指数(AHI) 38.10±2.51事件/h)的体重指数(35.20±0.57 vs 30.60±0.79 kg/m, p<0.001)、血糖水平(107.2±2.2 vs 98.0±2.5 mg/dl, p=0.045)、尿酸水平(6.17±0.10 vs 5.5±0.3 mg/dl, p=0.048)和左心室质量指数(LVMI)(115.80±2.39 vs 104.60±4.56 g/m, p=0.035)显著高于无OSA患者(平均AHI 3.02±0.25事件/h)。与非OSA患者相比,AH合并OSA患者颈股动脉脉波速度(PWVcf)(11.19±0.20 vs 10.10 m/s, p=0.014)和中枢收缩压(CSBP)(133.43±1.67 vs 125.22±3.41 mm Hg, p=0.027)较高。经cpap治疗的AH合并OSA患者随访10个月,60.9%患者PWVcf(从12.20±0.63降至10.05±0.43 m/s, p=0.009)达到正常水平(<10 m/s),收缩压(从143.8±132.7降至132.70±2.33 mm Hg, p=0.021)和舒张压(从93.80±3.31降至86.00±3.19 mm Hg, p=0.012)达到目标水平。患者中央收缩压下降(从130.30±3.97降至119.70±2.97 mm Hg, p=0.012),舒张压下降(从94.70±3.31降至87.10±2.36 mm Hg, p=0.013)。持续气道正压治疗(CPAP)联合降压治疗可降低AH合并中重度OSA患者的动脉僵硬度,有助于达到目标血压。